Prospect of Doripenem in Bangladesh Pharma Market

dc.contributor.authorHossain, Shahriar
dc.date.accessioned2019-02-26T09:47:47Z
dc.date.available2019-02-26T09:47:47Z
dc.date.issued12/23/2009
dc.descriptionThis thesis submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy (B.Pharm) in East West University, Dhaka, Bangladesh.
dc.description.abstractDoripenem is a novel carbapenem drug. It is broad spectrum antibiotic. Effort was given to find about the characteristics of the drug and whether it is suitable to launch in the Bangladesh market. Information was gathered from website, journal and books. For market fisibility study IMS, MIMS and QUIMP was observed. It was found that doripenem is non inferior to meropenem, imipenem and ertapenem. It can be used in the complicated urinary tract infections and complicated intra abdominal infections. Doripenem is not in Bangladesh yet. If it is launched doripenem market size would be 10,00,000 taka and its growth would be 10% first year, 25% second year, 15% in third year. From the information from market fisibilty study, swot analysis and product positioning it may be profitable to launch doripenem in Bangladesh.
dc.identifier.otherhttp://dspace.ewubd.edu:8080/handle/2525/2983
dc.identifier.urihttp://dspace.ewubd.edu/handle/2525/2983
dc.language.isoen_US
dc.publisherEast West University
dc.sourceEast West University Institutional Repository
dc.subjectDoripenem in Bangladesh Pharma Market
dc.titleProspect of Doripenem in Bangladesh Pharma Market
dc.typeThesis

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Shahriar_Hossain.pdf
Size:
1.01 MB
Format:
Adobe Portable Document Format

Collections